Region:Asia
Author(s):Geetanshi
Product Code:KRAA1087
Pages:86
Published On:January 2026

By Type:The market is segmented into various types of infusion services, including Intravenous (IV) Therapy, Total Parenteral Nutrition (TPN), Antibiotic Infusion, Chemotherapy Infusion, Pain Management Infusion, and Others. Among these, Intravenous (IV) Therapy is the leading sub-segment due to its widespread application in treating various medical conditions, including dehydration, infections, and chronic illnesses. The increasing preference for outpatient care and home-based treatments has further propelled the demand for IV therapy, making it a dominant choice for patients and healthcare providers alike.

By End-User:The end-user segmentation includes Home Care Patients, Long-term Care Facilities, Hospitals, Rehabilitation Centers, and Others. Home Care Patients represent the largest segment, driven by the growing trend of aging in place and the increasing number of patients preferring home-based treatments. This shift is supported by advancements in medical technology and the availability of skilled healthcare professionals who can provide high-quality care in a home setting.

The Thailand Home Infusion Services Market is characterized by a dynamic mix of regional and international players. Leading participants such as Bangkok Hospital, Bumrungrad International Hospital, Samitivej Hospital, Thonburi Healthcare Group, Phyathai Hospital, Vejthani Hospital, Bangkok Nursing Home, MedPark Hospital, Chulalongkorn Hospital, Siriraj Hospital, Piyavate Hospital, BNH Hospital, Ramkhamhaeng Hospital, Kasemrad Hospital, Bangkok Medical Center contribute to innovation, geographic expansion, and service delivery in this space.
The future of home infusion services in Thailand appears promising, driven by demographic shifts and technological advancements. As the elderly population continues to grow, the demand for personalized and patient-centric care models will increase. Additionally, the integration of telehealth services is expected to enhance patient monitoring and support, making home infusion more accessible. With ongoing investments in healthcare infrastructure, the market is poised for significant growth, addressing the evolving needs of patients and healthcare providers alike.
| Segment | Sub-Segments |
|---|---|
| By Type | Intravenous (IV) Therapy Total Parenteral Nutrition (TPN) Antibiotic Infusion Chemotherapy Infusion Pain Management Infusion Others |
| By End-User | Home Care Patients Long-term Care Facilities Hospitals Rehabilitation Centers Others |
| By Patient Demographics | Pediatric Patients Adult Patients Geriatric Patients Others |
| By Infusion Method | Continuous Infusion Intermittent Infusion Bolus Infusion Others |
| By Duration of Treatment | Short-term Treatment Long-term Treatment Others |
| By Geographic Distribution | Urban Areas Rural Areas Others |
| By Insurance Coverage | Private Insurance Public Insurance Out-of-Pocket Payments Others |
| Scope Item/Segment | Sample Size | Target Respondent Profiles |
|---|---|---|
| Home Infusion Therapy Patients | 150 | Patients currently receiving home infusion treatments |
| Healthcare Professionals | 100 | Nurses, pharmacists, and home healthcare providers |
| Caregivers of Patients | 80 | Family members and caregivers involved in home care |
| Healthcare Administrators | 70 | Managers and directors from hospitals and home healthcare agencies |
| Insurance Providers | 50 | Representatives from health insurance companies covering home healthcare |
The Thailand Home Infusion Services Market is valued at approximately USD 1.2 billion, reflecting significant growth driven by the increasing prevalence of chronic diseases, an aging population, and a rising preference for home healthcare services.